BioStone Animal Health Joins International Partnership to Develop Nipah Virus Vaccine and Companion Diagnostic Test for Pigs

BioStone will develop a DIVA ELISA to support vaccine evaluation and disease surveillance. Dallas–Fort Worth, TX — October 15, 2026 — BioStone Animal Health LLC is pleased to announce its participation in Duo-ProTectz, a three-year international research project led by The Pirbright Institute in the United Kingdom. The project aims to develop a bivalent vaccine…

BioStone Animal Health Announces Launch of the AsurDx Anaplasmosis Antibody Test Kit

Dallas–Fort Worth, TX – October 8, 2026 – BioStone Animal Health LLC proudly announces the launch of the AsurDx™ Anaplasmosis Antibody Test Kit, a rapid and sensitive indirect ELISA designed to detect antibodies against Anaplasma bacteria in bovine serum and plasma samples. Bovine anaplasmosis, primarily caused by Anaplasma marginale, is an infectious disease affecting cattle…